Canada markets closed

Khiron Life Sciences Corp. (KHRNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3866+0.0088 (+2.33%)
At close: 3:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.3778
Open0.3800
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.3681 - 0.3897
52 Week Range0.2660 - 0.6170
Volume355,117
Avg. Volume603,214
Market Cap57.912M
Beta (5Y Monthly)2.10
PE Ratio (TTM)N/A
EPS (TTM)-0.1650
Earnings DateApr. 29, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Khiron Comments on the Results of Project Twenty21 - UK´s Largest Observational Study into Medical Cannabis Products
    CNW Group

    Khiron Comments on the Results of Project Twenty21 - UK´s Largest Observational Study into Medical Cannabis Products

    Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, applauds the publication today in the accredited scientific journal "Psychopharmacology" of the first findings arising from Project Twenty 21, UK's first and largest national medical cannabis registry that was launched on November 7, 2019 at the Royal College of Psychiatrists in London.

  • Khiron to Present at Canaccord Genuity's Virtual Cannabis Conference
    CNW Group

    Khiron to Present at Canaccord Genuity's Virtual Cannabis Conference

    Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that Chairman Chris Naprawa will present live at Canaccord Genuity's 2021 Virtual Cannabis Conference on Tuesday, May 11, 2021 at 1:00 p.m. EDT (10:00 a.m. PDT).

  • Will Khiron Life Sciences (CVE:KHRN) Spend Its Cash Wisely?
    Simply Wall St.

    Will Khiron Life Sciences (CVE:KHRN) Spend Its Cash Wisely?

    We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...